Mixed outlook with identifiable growth catalysts from Georgia and Pennsylvania expansion and potential Texas market entry, offset by 14.8% projected revenue decline for 2026, expected losses, and regulatory uncertainty around federal cannabis reform and rescheduling. Zacks Rank #2 but with significant headwinds.
Articles that tag TRLV but are mainly about other companies.
Strong fundamentals including $74M free cash flow in H1 2026, 60% gross margin, $325M cash position, and historic NYSE listing as first U.S. cannabis company. Stock up 27% YTD outperforming S&P 500, though Q2 revenue declined 10% YoY due to restructuring.
Trulieve achieved a historic milestone as the first U.S. cannabis operator on the NYSE, signaling financial normalization and improved access to capital markets. However, the positive sentiment is tempered by acknowledgment of ongoing industry challenges.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
